A randomized phase of neoadjuvant chemotherapy for Head and Neck CancerThe addition of neoadjuvant chemotherapy, concurrent chemoradiotherapy promising approach promising approach for the treatment of patients with inoperable advanced head and neck cancer, according to the authors of a 10 – year follow -up of a randomized trial.
In a follow-up at 5 and 10 years after treatment report back Adriano Paccagnella, the SS Giovanni e Paolo Hospital in Venice, and there was no difference there was no difference in survival between the two groups. However, in patients who have not received surgery because their tumors were inoperable, neoadjuvant chemotherapy have a higher survival rate than patients who did not receive chemotherapy. Continue reading “According to the authors of a 10 year follow -up of a randomized trial.”